CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting
CRISPR Therapeutics Announces Transition of Chief Financial Officer
CRISPR Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
View All Press
CRISPR Therapeutics Corporate Presentation
Innovation Day Presentation
EHA 2022 (Exa-cel)
2022 EHA Oral Presentation (CTX130 COLBALT-LYM)
View All Presentations
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.
Continue